Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter, Neil J. Korman, Craig A. Elmets, et al.
Journal of the American Academy of Dermatology (2009) Vol. 60, Iss. 4, pp. 643-659
Closed Access | Times Cited: 455

Showing 1-25 of 455 citing articles:

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
April W. Armstrong, Charlotte Read
JAMA (2020) Vol. 323, Iss. 19, pp. 1945-1945
Closed Access | Times Cited: 1581
Psoriasis
C.E.M. Griffiths, April W. Armstrong, Jóhann E. Guðjónsson, et al.
The Lancet (2021) Vol. 397, Iss. 10281, pp. 1301-1315
Closed Access | Times Cited: 1461
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alice B. Gottlieb, Neil J. Korman, Kenneth B. Gordon, et al.
Journal of the American Academy of Dermatology (2008) Vol. 58, Iss. 5, pp. 851-864
Open Access | Times Cited: 768
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter, Neil J. Korman, Craig A. Elmets, et al.
Journal of the American Academy of Dermatology (2011) Vol. 65, Iss. 1, pp. 137-174
Closed Access | Times Cited: 444
Diagnosis and management of psoriasis.
Whan B. Kim, Dana Jerome, Jensen Yeung
PubMed (2017) Vol. 63, Iss. 4, pp. 278-285
Closed Access | Times Cited: 387
A Survey of the Structures of US FDA Approved Combination Drugs
Pradipta Das, Michael D. Delost, Munaum H. Qureshi, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 9, pp. 4265-4311
Closed Access | Times Cited: 232
Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures
Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, et al.
Journal of the American Academy of Dermatology (2020) Vol. 84, Iss. 2, pp. 432-470
Open Access | Times Cited: 224
Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
Caitriona Ryan, Muriel Sadlier, Edward De Vol, et al.
Journal of the American Academy of Dermatology (2015) Vol. 72, Iss. 6, pp. 978-983
Closed Access | Times Cited: 186
2021 European guideline for the management of vulval conditions
W I van der Meijden, M. J. Boffa, Bram ter Harmsel, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 7, pp. 952-972
Closed Access | Times Cited: 90
Ichthyosis
Carlos Gutiérrez-Cerrajero, Eli Sprecher, Amy S. Paller, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 43
Mechanisms of Action of Topical Corticosteroids in Psoriasis
Luís Uva, Diana Miguel, Catarina Pinheiro, et al.
International Journal of Endocrinology (2012) Vol. 2012, pp. 1-16
Open Access | Times Cited: 208
Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double‐blind, placebo‐controlled study
Georg Schett, J. Wollenhaupt, Kim Papp, et al.
Arthritis & Rheumatism (2012) Vol. 64, Iss. 10, pp. 3156-3167
Closed Access | Times Cited: 191
Vitamin D status in patients with chronic plaque psoriasis
Paolo Gisondi, Maurizio Rossini, Antonella Di Cesare, et al.
British Journal of Dermatology (2011) Vol. 166, Iss. 3, pp. 505-510
Closed Access | Times Cited: 150
Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent
Robert Bissonnette, Linda Stein Gold, David S. Rubenstein, et al.
Journal of the American Academy of Dermatology (2020) Vol. 84, Iss. 4, pp. 1059-1067
Open Access | Times Cited: 134
Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review
Aleksandra G. Florek, Catherine J. Wang, April W. Armstrong
Archives of Dermatological Research (2018) Vol. 310, Iss. 4, pp. 271-319
Closed Access | Times Cited: 118
Keratin 17: A Critical Player in the Pathogenesis of Psoriasis
Liang Jin, Gang Wang
Medicinal Research Reviews (2013) Vol. 34, Iss. 2, pp. 438-454
Closed Access | Times Cited: 113
Research gaps in psoriasis: Opportunities for future studies
Caitriona Ryan, Neil J. Korman, Joel M. Gelfand, et al.
Journal of the American Academy of Dermatology (2013) Vol. 70, Iss. 1, pp. 146-167
Closed Access | Times Cited: 113
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris – A randomized phase II study
John Koo, Stephen K. Tyring, William Philip Werschler, et al.
Journal of Dermatological Treatment (2015) Vol. 27, Iss. 2, pp. 120-127
Open Access | Times Cited: 108
Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO‐ABLE study
C. Paul, Linda Stein Gold, F. Cambazard, et al.
Journal of the European Academy of Dermatology and Venereology (2016) Vol. 31, Iss. 1, pp. 119-126
Open Access | Times Cited: 108
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Jürgen Brück, Ralf Dringen, Adriana Amasuno, et al.
Experimental Dermatology (2018) Vol. 27, Iss. 6, pp. 611-624
Open Access | Times Cited: 104
Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS)
M. Sala, Abdelhamid Elaı̈ssari, Hatem Fessi
Journal of Controlled Release (2016) Vol. 239, pp. 182-202
Closed Access | Times Cited: 95
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial
Kim Papp, Robert Bissonnette, Melinda Gooderham, et al.
BMC Dermatology (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 91
Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis
K. Thomas Robbins, Robert Bissonnette, Tomoko Maeda‐Chubachi, et al.
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 3, pp. 714-721
Closed Access | Times Cited: 84
Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment
Long Fu Xi, Zibei Lin, Fen Qiu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 339-352
Open Access | Times Cited: 63
Pathogenesis, multi-omics research, and clinical treatment of psoriasis
Jiadong Yu, Qixiang Zhao, Xiaoyan Wang, et al.
Journal of Autoimmunity (2022) Vol. 133, pp. 102916-102916
Closed Access | Times Cited: 58
Page 1 - Next Page

Scroll to top